Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2010 3
2011 4
2012 11
2013 18
2014 22
2015 23
2016 22
2017 16
2018 23
2019 22
2020 11
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 29180383

155 results
Results by year
Filters applied: . Clear all
Page 1
Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-α inhibitors or nonbiologic agents: a cohort study.
Desai RJ, Gagne JJ, Lii J, Liu J, Friedman S, Kim SC. Desai RJ, et al. CMAJ. 2017 Nov 27;189(47):E1438-E1447. doi: 10.1503/cmaj.161485. CMAJ. 2017. PMID: 29180383 Free PMC article.
Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study.
Desai RJ, Pawar A, Weinblatt ME, Kim SC. Desai RJ, et al. Arthritis Rheumatol. 2019 Jun;71(6):892-900. doi: 10.1002/art.40798. Epub 2019 Apr 29. Arthritis Rheumatol. 2019. PMID: 30552833 Free article. Clinical Trial.
Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
Winthrop KL, Baddley JW, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR. Winthrop KL, et al. JAMA. 2013 Mar 6;309(9):887-95. doi: 10.1001/jama.2013.1099. JAMA. 2013. PMID: 23462785 Free PMC article.
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.
Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Ouellet-Hellstrom R, Patkar NM, Solomon DH, Lewis JD, Xie F, Saag KG, Curtis JR. Grijalva CG, et al. JAMA. 2011 Dec 7;306(21):2331-9. doi: 10.1001/jama.2011.1692. Epub 2011 Nov 6. JAMA. 2011. PMID: 22056398 Free PMC article.
Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.
Mamtani R, Clark AS, Scott FI, Brensinger CM, Boursi B, Chen L, Xie F, Yun H, Osterman MT, Curtis JR, Lewis JD. Mamtani R, et al. Arthritis Rheumatol. 2016 Oct;68(10):2403-11. doi: 10.1002/art.39738. Arthritis Rheumatol. 2016. PMID: 27159030 Free PMC article. Clinical Trial.
Predictors of treatment initiation with tumor necrosis factor-α inhibitors in patients with rheumatoid arthritis.
Desai RJ, Rao JK, Hansen RA, Fang G, Maciejewski ML, Farley JF. Desai RJ, et al. J Manag Care Spec Pharm. 2014 Nov;20(11):1110-20. doi: 10.18553/jmcp.2014.20.11.1110. J Manag Care Spec Pharm. 2014. PMID: 25351972 Free article.
Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.
Lee WJ, Lee TA, Calip GS, Suda KJ, Briars L, Schumock GT. Lee WJ, et al. Inflamm Bowel Dis. 2018 Mar 19;24(4):883-891. doi: 10.1093/ibd/izx080. Inflamm Bowel Dis. 2018. PMID: 29562275
Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.
Kim SC, Solomon DH, Liu J, Franklin JM, Glynn RJ, Schneeweiss S. Kim SC, et al. Am J Med. 2015 May;128(5):539.e7-17. doi: 10.1016/j.amjmed.2014.11.025. Epub 2014 Dec 20. Am J Med. 2015. PMID: 25534420 Free PMC article.
155 results
Jump to page
Feedback